New scanner from Ventana was announced late last week. No experience with the device but looks like increased capacity from iScan Coreo with random access and continuous loading technology. More information from Ventana below as linked documents. The VENTANA iScan...
http://feedproxy.google.com/~r/DigitalPathologyBlog/~3/PTCW_eyW044/new-scanner-from-ventana.html
Greetings all; do any of you lovely Morbid Anatomy readers out there happen to have a high-resolution version of the above image, or know a book that contains it, or another way I might source it? Please send any suggestions to morbidanatomy@gmail.com. Thanks so much!
Full citation for image, from a 2010 Swann Gallery auction:
THE DANCE OF DEATH. 1919.
ATTRIBUTED TO JOSEF FENNEKER (1895-1956)
54 1/2x41 inches, 138 1/2x104 cm.
Condition B+: restoration along vertical and horizontal folds; minor restoration in margins.
Fenneker designed over three hundred movie posters. His recognizable style drew largely on German Expressionism combined with a flair of aesthetic decadence. Written by Fritz Lang, Totentanz is considered by The Internet Movie Database to be a "lost film [in which] a beautiful dancer's sexual allure is used by an evil cripple to entice men to their deaths. Falling in love with one of the potential victims, she is told by the cripple that he will set her free if her lover, actually a murderer himself, survives and escapes a bizarre labyrinthe which runs beneath the cripple's house" (www.imdb.com). Even without a signature, this poster is clearly the work of Fenneker. Although another image by Fenneker for this film exists, this particular version is previously unrecorded.
Estimate $2,000-3,000
Source:
http://morbidanatomy.blogspot.com/2012/10/seeking-hi-resolution-of-dance-of-death.html
For those who live in the New York City area and have not already had too much of Morbid Anatomy this season: I would love to see you this Friday at "Relics of the Weird," a book event for Colin Dickey's wonderful Afterlives of the Saints, wherein he will read from the book, and we will show and discuss artifacts of Catholicism drawn from the Morbid Anatomy Library permanent collection.
Full details follow; hope to see you there!
Relics of the Weird
Colin Dickey and Morbid Anatomy
Saturday October 27, 2012
7:00 pm
Word Book Store (126 Franklin Street, Brooklyn)
Get your creep on early! Colin Dickey (Afterlives of the Saints, Cranioklepty) and Brooklyn's own Morbid Anatomy will host a night in honor of some of the weirder relics in history, complete with slideshow and Halloween candy.
More here.
Image: "Incorruptible Saint" in Milan
Source:
http://morbidanatomy.blogspot.com/2012/10/relics-of-weird-colin-dickey-with.html
Take your Annual Meeting experiencemobile with the new ASCP app. The most current meeting information is available at your fingertips. Available for your iPhone or Android.
Courtesy of Dark Daily: During Pathology Informatics 2012, a record crowd gathered last week to explore how new technologies are reshaping both clinical laboratory informatics and anatomic pathology informatics. If there was clear consensus on any single point, it was...
The Institute of Medicine (IOM) has published its much anticipated study on the future use of the Department of Defense’s (DoD) biorepository (previously known as the AFIP Tissue Repository) which was created fromseveral decades of collecting tissue samples from military...
ARE YOU READY FOR PATHOLOGY VISIONS 2012? Register for Pathology Visions 2012 Pathology Visions will give you the opportunity to learn about real-world, practical applications in the ever-evolving field of digital pathology. The Digital Pathology Association’s annual meeting will give...
Wednesday 24th October 2012, 3:15pm GMT / 4:15pm CET What Is It? PathXL® Biobank is a highly configurable sample collection, tracking, storage, management and distribution platform that provides the flexibility required to build customised solutions across a range of biobank...
Source:
http://morbidanatomy.blogspot.com/2012/10/care-and-conservation-of-early-19th.html
Thanks to good friend and genius writer Richard Faulk--author of the unfortunately named but no less wonderful Gross America--The Morbid Anatomy Library has just been awarded the dubious honor of being voted one of the top 7 "Grossest Wonders of the USA" on CNN.
You can read Mr. Faulk's entire list, and his entry on The Morbid Anatomy Library, by clicking here. You can find out more about the elegantly and eruditely written book--and even buy a copy of your own!--by clicking here.
To find out more about the library, click here; for those curious to see this "weird art and antique medicine cum gallery and lecture space [which] hosts occasional classes in anthropmorphic taxidermy," please stop by open hours this Sunday, 1-6. More on that here.
Source:
http://morbidanatomy.blogspot.com/2012/10/morbid-anatomy-library-one-of-7.html
ARS MORIENDI
Loreto Prague, Loretánské nám.7, 118 00 Praha 1 – Hrad?any
Exhibition extended until 30th November.
The aim of the exhibition is, above all, to introduce to the public the hitherto unknown space of the crypt for benefactors beneath the church of the Nativity of Our Lord. A fascinating discovery in the crypt revealed unique Baroque mural paintings depicting motifs of Death and Resurrection – allegories of Time, symbols of fragility and transience of human existence. These frescos of exceptional quality were created in 1664 by the means of the special technique of chiaroscuro – employing exclusively the shades of black and grey. The work of their author, perhaps a Capuchin order painter, was derived from the Flemish and Dutch prints and was commissioned by the then patroness of Loreto, Countess Elisabeth Apollonia of Kolowrat. The main scene depicting the Raising of Lazarus was based on the famous etching by Rembrandt, which later inspired numerous artists across the centuries, including Van Gogh – the Loreto fresco is remarkable because it is a very early reaction to Rembrandt’s work created while he was still alive...... Part of the presentation will be dedicated to other interesting exhibits associated with the burial practices in Loreto – for example the unknown ground plan of the Lobkowicz crypt of patrons beneath Santa Casa, design of Castrum Doloris created in 1698 for the burial of the Count Václav Ferdinand of Lobkowicz, collection of the Baroque funerary textiles or several reliquary crosses which were part of the Loreto treasure and had not yet been exhibited.
The exhibition will also introduce the customs related to burying in the Capuchin order crypts. Borrowed for this occasion from the Brno crypt were Baroque coffin lids with painted decoration, portraits and coats of arms of selected donors who sought their final resting place with the Capuchins. The perception of the order spirituality of Franciscan observance in the funerary sphere is broadened by the presentation of two Baroque Franciscan convent mortuaries.
It rarely happens that an entirely unknown monument in the centre of Prague is discovered. The Loreto exhibition offers an opportunity to get more closely acquainted with the impressive crypt space decorated with unique paintings and with the Baroque ARS MORIENDI – The Art of Dying – the inner grasp of the end of human existence as a gate to eternal life.
Source:
http://morbidanatomy.blogspot.com/2012/10/ars-moriendi-art-of-dying-loreto-prague.html
At the Digital Pathology Associations (DPA) upcoming annual conference Pathology Visions, being held October 28-30, 2012 in Baltimore, MD, the College of American Pathologists (CAP) Pathology and Laboratory Quality Center will be featuring a special presentation to follow up from the Regulatory Panel featured at Pathology Visions 2011.
Indianapolis, IN (PRWEB) October 18, 2012
The DPA hosted a Regulatory Panel in 2011 titled Navigating Digital Pathologys Path to Patients that gave participants a new insight into the evolving regulatory process for digital pathology products. Now at Pathology Visions 2012, the DPA is yet again highlighting the movement towards validating whole slide images.
CAP Pathology and Laboratory Quality Centers presentation for Pathology Visions 2012 titled Recommendations for Validating Whole Slide Imaging for Diagnostic Purposes in Pathology will focus on answering the question: what needs to be done to validate a whole slide digital imaging system for diagnostic purposes before it is placed in clinical service? The panel making the presentation includes Dr. Liron Pantanowitz, MD, FCAP, Chair; Anil Parwani, MD, PhD, FCAP and Andrew Evans, MD,PhD, FCAP. These panelists conducted a systematic review of international literature and addressed intended use, preparation types, case numbers, equipment, personnel, and process to reach their final recommendations included in the presentation.
In addition to the Regulatory Update, there will be over 40 presenters featured at Pathology Visions 2012. These presentations give attendees the opportunity to earn 11 continuing medical education (CME) credits throughout the conference.
Registration for Pathology Visions is still open. Please click here to register now and visit our website for more information on the Regulatory Update, CME credit and a complete list of the presenters and their topics.
About the Digital Pathology Association
The Digital Pathology Association, located in Indianapolis, IN, was founded in 2009. Its mission is to facilitate education and awareness of digital pathology applications in healthcare and life sciences. Members are encouraged to share best practices and promote the use of technology among colleagues in order to demonstrate efficiencies, awareness, and its ultimate benefits to patient care. To learn more about the DPA and Pathology Visions, please visit our website.
Michael F. Ward, CAE Digital Pathology Association (DPA) 317.816.1630 101 Email Information
View original post here:
Pathology Visions 2012 to Offer Regulatory Update
Growing waistlines feed weight loss firm Rapid Nutrition's success
Brisbane, Queensland (PRWEB) October 18, 2012
Rapid Nutrition, whose flagship product Leisas Secret, a set of scientifically formulated weight loss and maintenance supplements, has already achieved considerable success both in Australia and overseas.
Rapid Nutritions listing will provide the necessary capital to support our international expansion plans, particularly into our target markets in the United States, India and neighboring Asian countries, Mr St Ledger says.
The company has already attracted the interest of large corporate investors as well as high net worth individuals in addition to being surrounded by a highly experienced advisory board.
Whilst it is always nice to successfully attract investment into the company, it also provides the added benefits of securing their expertise and support by assisting the company to identify acquisition candidates, which is an important part of our growth model.
Rapid Nutritions business plan is focused on three key areas:
1) Expanding our distribution in the USA, Asia, Europe and the Middle East.
2) Expand product range, technologies and intellectual property.
3) Enter into Joint Ventures and to acquire EBITDA positive acquisitions and then vend them into the listed public company to create a global conglomerate in the healthcare space for rapid and complete market penetration.
Read the rest here:
Rapidly Expanding Australian Natural Healthcare Company Goes Global
NEW YORK, NY--(Marketwire - Oct 17, 2012) - The global market for clinical nutrition products, at the manufacturers' level, should reach $28.4 billion in 2012, according to Kalorama Information. The healthcare market research publisher said that sales for clinical nutrition formulas increased 6.6% annually in the past four years due to expanding product lines in global markets, an aging population, increasing incidence of disease, a steady infant birth rate, recovering market conditions and several other factors. Growth from 2010 to 2012 showed the impact of the improving economic situation in the U.S. and other developed regions, according to the findings in The World Market for Clinical Nutrition Products, 5th Edition.
The report breaks out the market into three product segments: enteral food consumed orally such as nutritional drinks; parenteral food served to patients through feeding tubes; and infant nutrition. The infant formula segment was a major contributor to recent growth. Sales for infant formulas have increased substantially in global markets, especially in many Eastern European, Asian, and Middle Eastern regions. Additionally, an aging population and increased awareness of the relationship between health and nutrition are driving sales for all clinical nutrition products in most regions worldwide.
"The clinical nutrition market experienced a slowdown during 2009 due to the economic downturn in many developed regions," said Melissa Elder, author of the report. "Many manufacturers reported recovering sales during 2010, which continued throughout 2011 and 2012."
Growth during the forecast period is expected to be steady, continuing at the same pace in the next four years. Developments in follow-up formulas, organic formulas, and other innovative products will drive sales throughout the forecast period. The infant segment should lead growth, according to the report.
Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. Abbott, Nestle, Fresenius Kabi, Baxter and Mead Johnson are among the key players in this market.
Kalorama Information provides detailed profiles of companies in the market, a discussion of trends, and reviews of products, as well as specific market sizes by region and product type, in its full report, The World Market for Clinical Nutrition Products, 5th Edition.
About Kalorama Information Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.
More here:
Clinical Nutrition Products Market Bounces Back From Economic Downturn
by Chris Conte
NASHVILLE, Tenn.-The microbiology lab at Vanderbilt Hospitalis the kind of place that would make any high school biology drop-out cringe, filled with vials, test tubes and enough petri dishes to fill a small warehouse.
"I'm looking for specific structures that correlate to this organism," says lab technologist Tonya Snyder while looking into a microscope.
For those that might find this place overwhelming though you can be glad it is filled with people like Tonya Snyder.
"We look through the cultures, see what might be growing," she explains.
Over the last 19 years she's been looking through microscopes here, examining cultures from patients and helping doctors make diagnosis. But whatshe saw three weeks ago on a slide from a sickened patient though was the beginning of the meningitis outbreak.
"It's tragic," she said.
It's not that Tonya had never seen this type of aspergillus fumigatus fungus before, she'd just never seen it from someone's spinal fluid.
"I don't think anybody could've seen this coming," Tonya added.
When all of this is over withhistory will record this lab as being the place where fungal meningitis first was found.
Read more from the original source:
Inside Vanderbilt Lab Where Meningitis Outbreak Was Discovered
BioProtein Technology, a company that manufactures therapeutic proteins in the form of growth factors, has announced an alliance with Stem Longevity Research, a company partnered by Dr. Joseph Purita and CNC Reid Eckert.
(PRWEB) October 15, 2012
Stem Longevity Research has expertise in the medical applications of stem cells. Dr. Purita and Eckert will offer their high level of credibility to increase the exposure of BioProtein Technology's products on the part of physicians across the United States.
We are thrilled to welcome Dr. Purita and Reid Eckert to our team, as they are among the world's most respected stem cell researchers, said Paul Morave, National Sales Director for BioProtein Technology. With their endorsement of our products, we immediately gain a tremendous level of credibility in the eyes of doctors and medical professionals. Were very excited to begin our work with Stem Longevity Research and are looking forward to leveraging the knowledge they bring to our company.
Dr. Joseph Purita is one of the pioneers of PRP and stem cell injection research. His passion for stem cell research has helped him create the Institute of Regenerative and Molecular Orthopedics, where the standard is set for orthopedic stem cell treatments. Doctors from all over the world train in the use of PRP and stem cell treatment with Dr. Purita at the Institute.
Eckert specializes in the treatment of diseases and disorders for people of all ages. He is a certified nutritional counselor who is dedicated to bringing nutritional education and quality of life to those suffering from health challenges. Eckert also currently serves as a medical advisor for InHealth Media, a media and marketing firm that works with brands in the nutraceutical and sports nutrition industries.
BioProtein Technology offers a family of natural treatment therapies that combine the effective concepts of traditional medicine with modern technological breakthroughs. The company differentiates itself by dedicating unparalleled time and energy into a single raw material, giving its team complete top-down control of the manufacturing process.
The BioProtein Technology product line includes Velvet Antler Extract, which promotes anti-aging and naturally supports healthy cell regeneration and repair. This product balances hormones, modulates endocrine and immune systems and improves memory and cognition, among many other benefits. Other products include natural hormone and immune modulator Sub-L Tropin, topical anti-inflammatory solution Derma-T Tropin and Derma-T Tropin, an anti-aging skin care solution.
Its an honor to join the team of BioProtein Technology, a company that is doing groundbreaking work in creating top-quality alternative treatment products, said Eckert. Our goal is to significantly increase physicians awareness of this brand and the numerous benefits these products offer to individuals. Were very pleased to take part in what BioProtein Technology is doing for both doctors and their patients.
Stem Longevity Researchs work with BioProtein Technology will begin effective immediately. For more information, visit http://www.bioproteintech.com.
Read the original post:
Stem Longevity Research Links with BioProtein Technology - Renowned Partnership to Elevate Brand’s Innovative ...
Police have a DNA profile of the man who sexually assaulted a woman at North Adelaide last month, but the profile does not match any in the national database.
On September 6, a 23-year-old woman was walking home after having drinks with friends in OConnell St when she was attacked on Gover St just after midnight.
Police say the DNA profile of the offender does not match any match profiles on the National Criminal Investigation DNA Data Base, meaning the offender is unlikely to have a significant criminal history and could be a first time offender.
The suspect is described as aged in his 30s, about 175cm tall, with an olive complexion, shaved head and a calm, husky voice.
Posters depicting an image of the suspect have been distributed to businesses around North Adelaide.
We urge members of the public to take note of them and to read, have a look and to see if you recognise this person, Detective Acting Sergeant Matthew Lyon said.
Police said they have been reviewing CCTV footage and talking to local businesses as part of their ongoing enquiries.
They do not believe the attack is linked to others around North Adelaide, but have warned women to avoid walking alone at night and to stick to well-lit main roads.
Read the original here:
Police have rape suspect’s DNA profile
By Amanda Gardner HealthDay Reporter
TUESDAY, Oct. 16 (HealthDay News) -- Scientists have developed a new DNA test for colorectal cancer and for cancer precursors that seems to be not only accurate, but also noninvasive.
If approved by the U.S. Food and Drug Administration, experts say, the test could be a welcome alternative to colonoscopies, which require a lengthy and uncomfortable preparation.
"The study is interesting and may hold some promise in the future," said Dr. David Beck, chairman of the department of colon and rectal surgery at Ochsner Medical Center in New Orleans. "More testing needs to be done to confirm the findings, and we need to know how available the test will be and what it will cost."
"Currently, it is estimated that almost 50 percent of Americans have not been screened [by any method] for colorectal cancer," added Beck, who was not involved with the study. "Most tests are better than nothing. If further study confirms the usefulness of this test, it would be a significant help."
The researchers began with stool samples from more than 1,000 people who were undergoing colonoscopies for screening and who had just had a colonoscopy that identified a malignancy or pre-malignancy.
In previous studies, the researchers had identified 11 biomarkers that, when combined, could indicate the presence of cancerous or precancerous lesions.
The test has three components, said study author Graham Lidgard, senior vice president of research and development and chief science officer at Exact Sciences in Madison, Wis., which developed the test and funded the research.
The first identifies methylation in two genes. Methylation is a process that can turn off tumor suppressor genes that would normally help curb the proliferation of cancer cells. Abnormal methylation can be found in both colorectal cancers and pre-cancers.
The second component searches for DNA mutations in the K-ras gene. Mutations in this gene can spur tumor growth, and these mutations can be identified both in cancers and in pre-cancers.
Read this article:
New DNA Test Shows Promise for Spotting Colon Cancer
Source:
Source:
Source:
Source:
Source: